BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22608870)

  • 1. Pharmacologic issues in management of chronic disease.
    DeSevo G; Klootwyk J
    Prim Care; 2012 Jun; 39(2):345-62. PubMed ID: 22608870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a level 1 geriatric outpatient pharmacy screen.
    Powers JS; Edwards L; Carey A
    J Am Geriatr Soc; 2013 Apr; 61(4):654-5. PubMed ID: 23581924
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
    Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the risk of adverse drug events in older adults.
    Pretorius RW; Gataric G; Swedlund SK; Miller JR
    Am Fam Physician; 2013 Mar; 87(5):331-6. PubMed ID: 23547549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultivating quality: Reducing the use of potentially inappropriate medications in older adults.
    Bilyeu KM; Gumm CJ; Fitzgerald JM; Fox SW; Selig PM
    Am J Nurs; 2011 Jan; 111(1):47-52. PubMed ID: 21191234
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population.
    Lam MP; Cheung BM
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):187-97. PubMed ID: 22390561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia.
    Hazra M; Uchida H; Sproule B; Remington G; Suzuki T; Mamo DC
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):676-8. PubMed ID: 22176287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication safety: are we there yet?: Comment on "Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients".
    Schnipper JL
    Arch Intern Med; 2011 Jun; 171(11):1019-20. PubMed ID: 21670371
    [No Abstract]   [Full Text] [Related]  

  • 9. Polypharmacy in the elderly: maximizing benefit, minimizing harm.
    Ballentine NH
    Crit Care Nurs Q; 2008; 31(1):40-5. PubMed ID: 18316935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing polypharmacy: evidence from a simple quality improvement initiative.
    Little MO; Morley A
    J Am Med Dir Assoc; 2013 Mar; 14(3):152-6. PubMed ID: 23273343
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors leading to excessive polypharmacy.
    Hovstadius B; Petersson G
    Clin Geriatr Med; 2012 May; 28(2):159-72. PubMed ID: 22500536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy and prescribing quality in older people.
    Steinman MA; Landefeld CS; Rosenthal GE; Berthenthal D; Sen S; Kaboli PJ
    J Am Geriatr Soc; 2006 Oct; 54(10):1516-23. PubMed ID: 17038068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy with common diseases in hospitalized elderly patients.
    Mizokami F; Koide Y; Noro T; Furuta K
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):123-8. PubMed ID: 22387105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: a cohort study.
    Maio V; Del Canale S; Abouzaid S;
    J Clin Pharm Ther; 2010 Apr; 35(2):219-29. PubMed ID: 20456742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug dosing in patients with renal insufficiency in a hospital setting using electronic prescribing and automated reporting of estimated glomerular filtration rate.
    Nielsen AL; Henriksen DP; Marinakis C; Hellebek A; Birn H; Nybo M; Søndergaard J; Nymark A; Pedersen C
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):407-13. PubMed ID: 24373255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.
    Hamilton H; Gallagher P; Ryan C; Byrne S; O'Mahony D
    Arch Intern Med; 2011 Jun; 171(11):1013-9. PubMed ID: 21670370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records.
    Buck MD; Atreja A; Brunker CP; Jain A; Suh TT; Palmer RM; Dorr DA; Harris CM; Wilcox AB
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):84-92. PubMed ID: 19447361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Data analysis of elderly patients with Apodos. Inferior pharmacotherapy with many prescribers].
    Söderberg K; Bucht G; Nilsson JL
    Lakartidningen; 2013 Aug 21-Sep 3; 110(34-35):1466-8. PubMed ID: 24044182
    [No Abstract]   [Full Text] [Related]  

  • 20. Polypharmacy and its correlates in village health clinics across 10 provinces of Western China.
    Dong L; Yan H; Wang D
    J Epidemiol Community Health; 2010 Jun; 64(6):549-53. PubMed ID: 19854749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.